International Generosity Foundation Trust Reports New 6.7% Stake in Barinthus Biotherapeutics plc. (BRNS)

On April 13, 2026, the International Generosity Foundation Trust filed a Schedule 13D reporting a new 6.7% ownership stake in Barinthus Biotherapeutics plc. (BRNS). The trust acquired a total of 2,734,189 shares of common stock, with the triggering event occurring on February 3, 2026. According to the filing, the securities were acquired through a combination of purchases using the trust's working capital and various transfers or contributions. As a non-profit trust organized under Section 501(c) of the Internal Revenue Code, the reporting person stated that the shares were acquired for investment purposes and to support its charitable activities. The International Generosity Foundation Trust maintains sole voting and dispositive power over all reported shares. The trust indicated it may dispose of or acquire additional shares in the future based on market conditions and its charitable funding requirements. No other persons are reported to have rights to dividends or proceeds from these securities.